Amphstar Pharmaceuticals, Inc.
S&P 600
$23.78
+1.02%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Comfortable interest cover: operating profit covers interest about 5.5 times.
- Return on equity is healthy at 22%.
- Net profit margin is 13.6%.
- Current assets comfortably cover current liabilities (current ratio 4.02).
!Watch-points
- Higher leverage: debt-to-equity of 1.39 is above 1.
- Return on capital employed is on the lower side at 8.9%.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreGrey zone
2.47
This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.
Piotroski F-ScoreModerate
5 / 8
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 8 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap$1.01B
Current Price$ 23.78
High / Low$ 29.52 / 16.65
Stock P/E14.071006
Book Value$ 10.07
Dividend Yield0%
ROCE8.85%
ROE22.02%
Debt to Equity1.39
Current Ratio4.02
P/B Ratio1.3166491
EPS$ 2.03
Debt$619.71M
PAT Margin13.63%
Cash PAT$129.74M
ICR5.51